Shareholders are scheduled to vote on Novartis’s planned spin-off of its Alcon eye care unit. On Thursday, at the annual general meeting of Swiss drugmaker Novartis, shareholders came in heavily at the drugmaker for the hike in drug prices. Novartis… Read More ›